Bank Julius Baer & Co
PRVB

Bank Julius Baer & Co’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Bank Julius Baer & Co’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,305
Closed -$11K – 880
2021
Q2 		$11K Buy
1,305
+55
+4% +$444 ﹤0.01% 780
2021
Q1 		$13K Buy
+1,250
New +$17.6K ﹤0.01% 770

Other funds holding PRVB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Bank Julius Baer & Co's PRVB Position: Q3 2021 in Review

Bank Julius Baer & Co sold out of Provention Bio, Inc. Common Stock (PRVB) in Q3 2021, closing a stake of 1,305 shares — an estimated $11K sold.

Bank Julius Baer & Co first reported a position in PRVB in Q1 2021 and held it in 2 quarters. The position peaked at $13K in Q1 2021. 115 funds tracked by Wall St. Rank hold PRVB as of Q3 2021.

  • Bank Julius Baer & Co reported no remaining Provention Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 1,305 Provention Bio, Inc. Common Stock shares in Q3 2021, an estimated $11K.
  • Bank Julius Baer & Co first reported a position in Provention Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Bank Julius Baer & Co's Provention Bio, Inc. Common Stock position peaked at $13K in Q1 2021.
  • 115 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q3 2021.

Based on Bank Julius Baer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.